JamesG.ZangrilliMD
Pulmonology • Spring House, PAAsthma & COPD, Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Portfolio Clinical Leader, Tremfya
Dr. Zangrilli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Janssen Research and Development LLC
1400 McKean Rd
Spring House, PA 19477- Is this information wrong?
Summary
- Dr. James Zangrilli is a pulmonologist in Philadelphia, PA. He received his medical degree from Sidney Kimmel Medical College and was in active practice through 2015 and continues to work full time in pharmaceutical drug development. He specializes in asthma & copd, critical care medicine, interstitial lung diseases, and pleural disease and is experienced in critical care medicine and general pulmonology.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1995- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1988 - 1991
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1988
Certifications & Licensure
PA State Medical License 1992 - 2024
Publications & Presentations
PubMed
- 76 citationsEosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.Liam G Heaney, Luis Pérez de Llano, Mona Al-Ahmad, Vibeke Backer, John Busby, Giorgio Walter Canonica, George Christoff, Borja G. Cosío, J. Mark FitzGerald, Enrico Hef...> ;Chest. 2021 Apr 19
- 18 citationsOral Corticosteroid Treatment Patterns of Patients in the United States with Persistent AsthmaTrung N. Tran, Sharon MacLachlan, Wesley Hicks, Jieruo Liu, Yen Chung, James Zangrilli, Annalisa Rubino, Michael L. Ganz> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Jan 1
- 78 citationsOnset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asth...Tim W Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis, Borja G. Cosío, Njira L Lugogo, Arjun Mohan, Annie Burden, L. McDermott, Esth...> ;The Lancet. Respiratory Medicine. 2021 Mar 1
- Join now to see all
Journal Articles
- Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe AsthmaJames G Zangrilli, Michael E Wechsler, The European Respiratory Journal
Professional Memberships
- Fellow
- Member
Industry Relationships
- Executive Medical Director, AstraZenecaGlobal Medical Affairs, Respiratory Biologics2016 - Present
- Senior Medical Director, TevaRespiratory R&D2013 - 2016
- Medical Director, AstraZenecaRespiratory TA2008 - 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
